3681 - 3690 of 9104 Results
Title
Year
- An mGlu4‐Positive Allosteric Modulator Alleviates Parkinsonism in Primates2018RESTRICTEDTitle: An mGlu4‐Positive Allosteric Modulator Alleviates Parkinsonism in PrimatesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1619End Page: 1631Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27462Citation Count: 58
-
OPENTitle: Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation CarriersJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: 5Start Page: 888End Page: 894Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26469Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26469Citation Count: 2
-
OPENTitle: A role for the autophagy receptor NBR1 in the degradation of tau aggregatesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 214Issue #:Start Page: 107060End Page: 107060Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2025.107060Best OA location URL: https://doi.org/10.1016/j.nbd.2025.107060Citation Count: 3
- Structure based design, synthesis and identification of novel covalent reversible dual TLR2/TLR9 small molecule antagonists2025RESTRICTEDTitle: Structure based design, synthesis and identification of novel covalent reversible dual TLR2/TLR9 small molecule antagonistsJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 124Issue #:Start Page: 130259End Page: 130259Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2025.130259Citation Count: 3
-
OPENTitle: Changes in kynurenine pathway metabolism in Parkinson patients with L‐DOPA‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 142Issue #: 5Start Page: 756End Page: 766Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.14104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14104Citation Count: 117
-
OPENTitle: Pharmacodynamic, pharmacokinetic and rat brain receptor occupancy profile of NLX-112, a highly selective 5-HT1A receptor biased agonistJournal Name: Naunyn-Schmiedeberg's Archives of PharmacologyPublisher: Springer Science and Business Media LLCVol: 398Issue #: 1Start Page: 991End Page: 1002Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00210-024-03323-0Best OA location URL: https://hal.science/hal-04932477/documentCitation Count: 1
- Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent manner2017RESTRICTEDTitle: Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent mannerJournal Name: Biochimica et Biophysica Acta (BBA) - General SubjectsPublisher: Elsevier BVVol: 1861Issue #: 4Start Page: 922End Page: 935Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbagen.2017.01.021Citation Count: 18
-
OPENTitle: Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay StudyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 19Issue #: 6Start Page: 1611End Page: 1611Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms19061611Best OA location URL: https://www.mdpi.com/1422-0067/19/6/1611/pdf?version=1527671383Citation Count: 28
-
OPENTitle: Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older personsJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page: e12255End Page: e12255Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12255Best OA location URL: https://doi.org/10.1002/trc2.12255Citation Count: 47
-
OPENTitle: Changes in Plasma Amyloid β 1–42 Peptide and Total Tau Protein from Normal Cognition to Sever-Stage Alzheimer’s Disease Using an Immunomagnetic Reduction AssayJournal Name: ACS OmegaPublisher: American Chemical Society (ACS)Vol: 11Issue #: 25Start Page: 36855End Page: 36865Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acsomega.6c00355Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acsomega.6c00355?ref=article_openPDFCitation Count: 0